| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 2.81e-06 | 2 | 34 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 2.81e-06 | 2 | 34 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 3.10e-05 | 36 | 34 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 5.88e-05 | 7 | 34 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | IgG binding | 1.53e-04 | 11 | 34 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 2.53e-04 | 14 | 34 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.27e-03 | 31 | 34 | 2 | GO:0099604 | |
| GeneOntologyBiologicalProcess | type III hypersensitivity | 2.95e-05 | 5 | 36 | 2 | GO:0001802 | |
| GeneOntologyBiologicalProcess | regulation of type III hypersensitivity | 2.95e-05 | 5 | 36 | 2 | GO:0001803 | |
| GeneOntologyBiologicalProcess | positive regulation of type III hypersensitivity | 2.95e-05 | 5 | 36 | 2 | GO:0001805 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 5.35e-05 | 42 | 36 | 3 | GO:0002675 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 1.32e-04 | 10 | 36 | 2 | GO:0002894 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 1.32e-04 | 10 | 36 | 2 | GO:0001798 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 1.61e-04 | 11 | 36 | 2 | GO:0002892 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 1.61e-04 | 11 | 36 | 2 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 2.17e-04 | 67 | 36 | 3 | GO:0002673 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 2.28e-04 | 13 | 36 | 2 | GO:0001788 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 3.07e-04 | 15 | 36 | 2 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 3.07e-04 | 15 | 36 | 2 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 3.07e-04 | 15 | 36 | 2 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 3.96e-04 | 17 | 36 | 2 | GO:0002866 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis, engulfment | 4.45e-04 | 18 | 36 | 2 | GO:0060100 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane invagination | 4.45e-04 | 18 | 36 | 2 | GO:1905155 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.45e-04 | 18 | 36 | 2 | GO:0042590 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 4.97e-04 | 19 | 36 | 2 | GO:0002883 | |
| GeneOntologyBiologicalProcess | response to caffeine | 6.09e-04 | 21 | 36 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 7.32e-04 | 23 | 36 | 2 | GO:0002863 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis, engulfment | 7.98e-04 | 24 | 36 | 2 | GO:0060099 | |
| GeneOntologyBiologicalProcess | regulation of membrane invagination | 8.66e-04 | 25 | 36 | 2 | GO:1905153 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 8.66e-04 | 25 | 36 | 2 | GO:0002524 | |
| GeneOntologyBiologicalProcess | response to interferon-alpha | 9.38e-04 | 26 | 36 | 2 | GO:0035455 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 1.01e-03 | 27 | 36 | 2 | GO:0002864 | |
| GeneOntologyBiologicalProcess | ERAD pathway | 1.16e-03 | 119 | 36 | 3 | GO:0036503 | |
| MousePheno | decreased susceptibility to autoimmune hemolytic anemia | 3.06e-05 | 5 | 25 | 2 | MP:0004828 | |
| MousePheno | abnormal susceptibility to infection | 1.29e-04 | 672 | 25 | 7 | MP:0001793 | |
| MousePheno | abnormal macrophage antigen presentation | 1.37e-04 | 10 | 25 | 2 | MP:0002454 | |
| MousePheno | decreased susceptibility to induced arthritis | 1.87e-04 | 63 | 25 | 3 | MP:0003436 | |
| MousePheno | decreased susceptibility to induced joint inflammation | 1.87e-04 | 63 | 25 | 3 | MP:0003079 | |
| MousePheno | abnormal response to infection | 1.89e-04 | 714 | 25 | 7 | MP:0005025 | |
| MousePheno | abnormal response to antigen | 2.09e-04 | 726 | 25 | 7 | MP:0020000 | |
| MousePheno | increased susceptibility to infection | 2.10e-04 | 504 | 25 | 6 | MP:0002406 | |
| Domain | IGc2 | 1.05e-03 | 235 | 36 | 4 | SM00408 | |
| Domain | Ig_sub2 | 1.05e-03 | 235 | 36 | 4 | IPR003598 | |
| Domain | ig | 5.78e-03 | 190 | 36 | 3 | PF00047 | |
| Domain | Immunoglobulin | 5.78e-03 | 190 | 36 | 3 | IPR013151 | |
| Domain | - | 8.42e-03 | 663 | 36 | 5 | 2.60.40.10 | |
| Domain | IG | 8.48e-03 | 421 | 36 | 4 | SM00409 | |
| Domain | Ig_sub | 8.48e-03 | 421 | 36 | 4 | IPR003599 | |
| Domain | Ig_2 | 8.71e-03 | 73 | 36 | 2 | PF13895 | |
| Domain | Ig-like_fold | 1.09e-02 | 706 | 36 | 5 | IPR013783 | |
| Domain | IG_LIKE | 1.43e-02 | 491 | 36 | 4 | PS50835 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 9.00e-05 | 46 | 27 | 3 | MM15837 | |
| Pubmed | Reprogramming tumour-associated macrophages to outcompete cancer cells. | 1.67e-07 | 11 | 36 | 3 | 37380769 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28814603 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8611682 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 16409296 | ||
| Pubmed | Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. | 1.04e-06 | 2 | 36 | 2 | 37733444 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28289219 | ||
| Pubmed | Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. | 1.04e-06 | 2 | 36 | 2 | 35273604 | |
| Pubmed | IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. | 1.04e-06 | 2 | 36 | 2 | 16305642 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9257847 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21124939 | ||
| Pubmed | Mouse FcgammaRI: identification and functional characterization of five new alleles. | 1.04e-06 | 2 | 36 | 2 | 10752630 | |
| Pubmed | Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. | 1.04e-06 | 2 | 36 | 2 | 24430180 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30744065 | ||
| Pubmed | Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. | 1.04e-06 | 2 | 36 | 2 | 17124586 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31211699 | ||
| Pubmed | Suppression of the antiviral response by an influenza histone mimic. | 1.04e-06 | 2 | 36 | 2 | 22419161 | |
| Pubmed | Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. | 1.04e-06 | 2 | 36 | 2 | 38885133 | |
| Pubmed | Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. | 1.04e-06 | 2 | 36 | 2 | 8480181 | |
| Pubmed | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. | 1.04e-06 | 2 | 36 | 2 | 29576375 | |
| Pubmed | Novel Fc gamma receptor I family gene products in human mononuclear cells. | 1.04e-06 | 2 | 36 | 2 | 1430234 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15835266 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 18245810 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 16849450 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8663283 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25231998 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30190171 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8478020 | ||
| Pubmed | FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides. | 1.04e-06 | 2 | 36 | 2 | 31554601 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 38524127 | ||
| Pubmed | Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. | 1.04e-06 | 2 | 36 | 2 | 2136886 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 1830050 | ||
| Pubmed | FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway. | 1.04e-06 | 2 | 36 | 2 | 30552619 | |
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 1.04e-06 | 2 | 36 | 2 | 35833115 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8077658 | ||
| Pubmed | Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. | 1.04e-06 | 2 | 36 | 2 | 15528358 | |
| Pubmed | Functional characteristics of the high affinity IgG receptor, FcγRI. | 1.04e-06 | 2 | 36 | 2 | 21325219 | |
| Pubmed | Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. | 1.04e-06 | 2 | 36 | 2 | 14991835 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 1402657 | ||
| Pubmed | The involvement of FcR mechanisms in antibody-mediated rejection. | 1.04e-06 | 2 | 36 | 2 | 18049118 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30636035 | ||
| Pubmed | Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. | 3.12e-06 | 3 | 36 | 2 | 16841095 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12427132 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26056254 | ||
| Pubmed | The essential role of complement in antibody-mediated resistance to Salmonella. | 3.12e-06 | 3 | 36 | 2 | 30179254 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 8697799 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23728777 | ||
| Pubmed | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. | 3.12e-06 | 3 | 36 | 2 | 22287715 | |
| Pubmed | Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice. | 3.12e-06 | 3 | 36 | 2 | 23898046 | |
| Pubmed | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. | 3.12e-06 | 3 | 36 | 2 | 22493081 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 16543474 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24161960 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12707052 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22003208 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22046413 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19657115 | ||
| Pubmed | Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. | 3.12e-06 | 3 | 36 | 2 | 33032297 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9763663 | ||
| Pubmed | C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes. | 3.12e-06 | 3 | 36 | 2 | 28432146 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12594281 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30297432 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12875993 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 15880819 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28924242 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9892619 | ||
| Pubmed | Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. | 6.24e-06 | 4 | 36 | 2 | 16455953 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 9551950 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 1379234 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 12517949 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16452176 | ||
| Pubmed | The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity. | 6.24e-06 | 4 | 36 | 2 | 2957319 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 28028748 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 17182593 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16517729 | ||
| Pubmed | Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. | 6.24e-06 | 4 | 36 | 2 | 29511065 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 15485887 | ||
| Pubmed | Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. | 6.24e-06 | 4 | 36 | 2 | 12898452 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 10770797 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21169548 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 9171347 | ||
| Pubmed | Fcgamma receptor cross-linking stimulates cell proliferation of macrophages via the ERK pathway. | 6.24e-06 | 4 | 36 | 2 | 19996316 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 12705859 | ||
| Pubmed | Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10. | 6.24e-06 | 4 | 36 | 2 | 15850792 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 12528127 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 31562320 | ||
| Pubmed | Dynamic macrophage "probing" is required for the efficient capture of phagocytic targets. | 6.24e-06 | 4 | 36 | 2 | 21135140 | |
| Pubmed | Fc receptor regulation of protective immunity against Chlamydia trachomatis. | 6.24e-06 | 4 | 36 | 2 | 11872097 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 10760808 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 9490697 | ||
| Pubmed | Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. | 6.24e-06 | 4 | 36 | 2 | 16585547 | |
| Pubmed | 9.36e-06 | 276 | 36 | 5 | 28319085 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 17053192 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 2944118 | ||
| Pubmed | Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. | 1.04e-05 | 5 | 36 | 2 | 9653099 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 1531670 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 28852207 | ||
| Pubmed | A role for antibody and Fc receptor in the clearance of Brugia malayi microfilariae. | 1.04e-05 | 5 | 36 | 2 | 11920579 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 19050295 | ||
| Pubmed | Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice. | 1.04e-05 | 5 | 36 | 2 | 10051626 | |
| Pubmed | Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. | 1.04e-05 | 5 | 36 | 2 | 17485663 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 14679059 | ||
| GeneFamily | Immunoglobulin like domain containing | 7.92e-05 | 193 | 22 | 4 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.62e-02 | 161 | 22 | 2 | 593 | |
| GeneFamily | EF-hand domain containing | 2.88e-02 | 219 | 22 | 2 | 863 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.58e-06 | 180 | 36 | 5 | M8239 | |
| Coexpression | KESHELAVA_MULTIPLE_DRUG_RESISTANCE | 4.86e-06 | 82 | 36 | 4 | M12618 | |
| Coexpression | GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 7.65e-06 | 200 | 36 | 5 | M9562 | |
| Coexpression | CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP | 2.74e-05 | 6 | 36 | 2 | M41151 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 8.46e-05 | 1394 | 36 | 9 | M9585 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 1.01e-05 | 168 | 36 | 4 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-05 | 185 | 36 | 4 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 186 | 36 | 4 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.53e-05 | 187 | 36 | 4 | 23be50d81f4404a609dea821e1a66d221c0e0615 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 190 | 36 | 4 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.67e-05 | 191 | 36 | 4 | 367d300da3925e0a329271b5f19483a37265a878 | |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 1.74e-05 | 193 | 36 | 4 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid-Microglia|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-05 | 198 | 36 | 4 | 901cd39cb84f1907f2f5d27221979c854bd3b40e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-05 | 198 | 36 | 4 | cc292aa8518d5ef8940e2327f2f07d584a996d90 | |
| ToppCell | NS-moderate-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-05 | 198 | 36 | 4 | 1791f1b1195ac1735ca2c1e6adf04a7f39d63ac1 | |
| ToppCell | Sepsis-Leuk-UTI|Sepsis / Disease, condition lineage and cell class | 2.00e-05 | 200 | 36 | 4 | 7d92b24c0c888dd46e40b7e3c6c2645c3604f132 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-04 | 141 | 36 | 3 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 156 | 36 | 3 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 156 | 36 | 3 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 157 | 36 | 3 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 157 | 36 | 3 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Ciliated_cells-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.00e-04 | 162 | 36 | 3 | 5319603f7ba3f48126dcf2ba9ae604be11bf2577 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | b83a35c4426d66b5734a98fa6c72b345fe462030 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.05e-04 | 163 | 36 | 3 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | d2b5f51af7fcffddebe997ee302bacbd85d76852 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-04 | 166 | 36 | 3 | 9fa90d9d484563d44738bb2c6eb0775dffc4d549 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.34e-04 | 168 | 36 | 3 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.51e-04 | 171 | 36 | 3 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | 8d6df5938cef542f23259ce471eea1a1afbed03c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | 2af54c3427aacfa232e2aca6003b4a8ecb8bba66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | eca643b8f5b92aeed5a77c94b4301fd8100f9401 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.76e-04 | 175 | 36 | 3 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 3.76e-04 | 175 | 36 | 3 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | VE-mono2-|VE / Condition, Cell_class and T cell subcluster | 4.08e-04 | 180 | 36 | 3 | 188e7c65e9a86771f89029b18dfb3216b2c9d7d7 | |
| ToppCell | VE-mono2|VE / Condition, Cell_class and T cell subcluster | 4.08e-04 | 180 | 36 | 3 | 494d00672f20ceffa7054a31e617fb7ec72e56e9 | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 4.35e-04 | 184 | 36 | 3 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.42e-04 | 185 | 36 | 3 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.49e-04 | 186 | 36 | 3 | fc6e591089c87a66653c8e552be9c0fe0c82ecd5 | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.49e-04 | 186 | 36 | 3 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.49e-04 | 186 | 36 | 3 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.49e-04 | 186 | 36 | 3 | cb4ea1bc1427230070e9696baeda7de241c354b1 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-04 | 186 | 36 | 3 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.49e-04 | 186 | 36 | 3 | 6575ec6a626cdea169ffd185d47828dfaa29475d | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.49e-04 | 186 | 36 | 3 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 4.49e-04 | 186 | 36 | 3 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 188 | 36 | 3 | ecbba19eebba21b986caa99de78ea4245fde3600 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 188 | 36 | 3 | 72a1ee136d77c77e44793a512f60b5f7815a073a | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 188 | 36 | 3 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.70e-04 | 189 | 36 | 3 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.70e-04 | 189 | 36 | 3 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | 368C-Myeloid-Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-04 | 189 | 36 | 3 | e62355be0d136e2b7c739848022292e9c6af7392 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-04 | 189 | 36 | 3 | 3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.70e-04 | 189 | 36 | 3 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.70e-04 | 189 | 36 | 3 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.78e-04 | 190 | 36 | 3 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.78e-04 | 190 | 36 | 3 | 5e0e4a48159ec05ba1b599752b769a7b4da08588 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.78e-04 | 190 | 36 | 3 | 081b7bc07b6e5685e8a91b9ae6c1141623723700 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-04 | 190 | 36 | 3 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-04 | 190 | 36 | 3 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-04 | 190 | 36 | 3 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-04 | 191 | 36 | 3 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-04 | 191 | 36 | 3 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.85e-04 | 191 | 36 | 3 | bce138f067b8962ecef1ddec6511a3f142d81d78 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.92e-04 | 192 | 36 | 3 | 7e7383093efaadceadd4d1f900c2d39cd690102e | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 4.92e-04 | 192 | 36 | 3 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.92e-04 | 192 | 36 | 3 | 4e3deefd30adb7bf1eba294610eed3d077aa9418 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.00e-04 | 193 | 36 | 3 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 193 | 36 | 3 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.00e-04 | 193 | 36 | 3 | 5a4accf3af236ff285942163c45277a80263f421 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.00e-04 | 193 | 36 | 3 | 2684fa361baaa9dc7a18a39ed11c0759e78e4418 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-04 | 193 | 36 | 3 | 2653f83bc0289abdb4270c176ebdc24242600f9a | |
| ToppCell | wk_08-11-Hematologic-Myeloid-CX3CR1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.00e-04 | 193 | 36 | 3 | afc20433b5abc9b430751a2aa8d93b0fd136a888 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 5.00e-04 | 193 | 36 | 3 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.08e-04 | 194 | 36 | 3 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | Control-Classical_Monocyte|Control / Disease condition and Cell class | 5.08e-04 | 194 | 36 | 3 | 9e33e1b54b4114f9e6981819834bb796ed7192b5 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 194 | 36 | 3 | 260649f5c4aeaa9cbf5ed5ae5e9f293d75bb0457 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 194 | 36 | 3 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 194 | 36 | 3 | fad22d5cf62016cad979e6943e357106d8d2a4b4 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|myeloid / Lineage, cell class and subclass | 5.15e-04 | 195 | 36 | 3 | 15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.15e-04 | 195 | 36 | 3 | 518cc3baeb7cf2ad068692cbe85fd75be67f1872 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.15e-04 | 195 | 36 | 3 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 5.15e-04 | 195 | 36 | 3 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.15e-04 | 195 | 36 | 3 | d87c83d2d421c9291d0a10bc9db850e9fb337667 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|COVID-19_Severe / Disease condition and Cell class | 5.15e-04 | 195 | 36 | 3 | 787ea9f38ad8e2a836222ca97f4d927f7e79517d | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.15e-04 | 195 | 36 | 3 | 9c9634906168239cf978adb398787692437bf9e7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.23e-04 | 196 | 36 | 3 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.23e-04 | 196 | 36 | 3 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.23e-04 | 196 | 36 | 3 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 5.23e-04 | 196 | 36 | 3 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 5.23e-04 | 196 | 36 | 3 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | Enterocyte-C_05|Enterocyte / shred on cell type and cluster | 5.23e-04 | 196 | 36 | 3 | c307e5a70186567c62da938caa21749dc0e929d0 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.23e-04 | 196 | 36 | 3 | b2aee2f67da373a10b0c25e7797e30e3811543a8 | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|COVID-19 / Condition, Lineage and Cell class | 5.31e-04 | 197 | 36 | 3 | 4a9c61b37c938bb26929593007d713382ae1eb79 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.31e-04 | 197 | 36 | 3 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.31e-04 | 197 | 36 | 3 | 383d598ce3f8f5fc98bef3300e4cf7b6992aec9c | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.31e-04 | 197 | 36 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.31e-04 | 197 | 36 | 3 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | control-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.31e-04 | 197 | 36 | 3 | 8819db1550bf14566c6d33d97f7f83419e867ace | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|World / disease group, cell group and cell class | 5.31e-04 | 197 | 36 | 3 | 16cf3939e700aef1e16159f0652ba2dfad287e7a | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.31e-04 | 197 | 36 | 3 | 3cc4e56a77f96a43f9b5a24cf1b9524c927ef795 | |
| ToppCell | proximal-Hematologic-Alveolar_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.39e-04 | 198 | 36 | 3 | a5deecd8809bc5b38ffda02143598ad0145e2559 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid-Microglia|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.39e-04 | 198 | 36 | 3 | c0d33629438504a1545e07f0e5af2e76f50fd55b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.39e-04 | 198 | 36 | 3 | 2b724d2a36843801984d46a969d33149b76c9771 | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.39e-04 | 198 | 36 | 3 | 77f41f0e0895b7c732bab1fd2e047f2ed31cbd9d | |
| Disease | COVID-19, osteoarthritis | 2.56e-04 | 20 | 35 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 4.36e-04 | 26 | 35 | 2 | EFO_0010366 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 5.07e-04 | 28 | 35 | 2 | DOID:8466 (biomarker_via_orthology) | |
| Disease | respiratory failure, COVID-19 | 5.44e-04 | 29 | 35 | 2 | EFO_0009686, MONDO_0100096 | |
| Disease | prostate cancer (implicated_via_orthology) | 7.05e-04 | 33 | 35 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | COVID-19 symptoms measurement | 7.94e-04 | 35 | 35 | 2 | EFO_0600019 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 1.14e-03 | 42 | 35 | 2 | DOID:612 (is_implicated_in) | |
| Disease | age-related macular degeneration, COVID-19 | 3.05e-03 | 69 | 35 | 2 | EFO_0001365, MONDO_0100096 | |
| Disease | Self-injurious behavior | 3.88e-03 | 78 | 35 | 2 | HP_0100716 | |
| Disease | interleukin 10 measurement | 3.88e-03 | 78 | 35 | 2 | EFO_0004750 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIQKYLEIYWETDYN | 606 | A6NHC0 | |
| LQKQYYKWILTRNYK | 721 | O14646 | |
| YCNSNEWQVYIEKYI | 1676 | Q6ZS30 | |
| ERLEEYKWNYLDQYI | 911 | O75140 | |
| AWKDKLVYNVLYYRN | 126 | Q92637 | |
| EYLALWIYKYKENVT | 31 | Q8WWB3 | |
| KLWELLYKLQFVYTY | 1446 | Q96RV3 | |
| EDYNDKYWDQRYTIV | 421 | Q9BSJ2 | |
| QQLCIYWTKYYDFKN | 266 | P00973 | |
| LQYLKQTLYEKWGEY | 201 | Q7Z6J2 | |
| RADSYYEYLLKQWIQ | 461 | Q9UKM7 | |
| YINRKKKVWDYNYDD | 306 | P48551 | |
| KRRWYKTENEYYLLQ | 156 | Q5VTY9 | |
| DYRKQWDQYVKELYE | 76 | Q9UKL6 | |
| VYDYKIAREYNWNVK | 286 | Q8N7H5 | |
| GYWEKLNSNLEYVKY | 521 | A4D1B5 | |
| WNALEKYVTEIITYY | 506 | O75342 | |
| AWKDKLVYNVLYYRN | 126 | P12314 | |
| IIDHYKWQKFVYIYD | 136 | P42261 | |
| NVLWEKLDDYVYYVR | 451 | Q8WU17 | |
| KSYILYDLQEATWYE | 1531 | O60469 | |
| QQDYTKAWEEYYKKQ | 641 | Q92945 | |
| TDYKNKDWVFINYTY | 431 | Q15208 | |
| QWIYYLQKAVKTLKY | 371 | Q96DL1 | |
| NSEILDWDIYQYYKF | 276 | Q5TEA6 | |
| YKLYWRNLRKQDYQE | 391 | Q8TBE7 | |
| KKIYQDAYRAEWQVY | 96 | Q00059 | |
| FLLLYQKKGQWYEIY | 96 | P48736 | |
| QKKGQWYEIYDKYQV | 101 | P48736 | |
| WYEIYDKYQVVQTLD | 106 | P48736 | |
| KITDAYLDQYLWYEA | 916 | Q6P2Q9 | |
| LKYLWEKDYQVLVFY | 181 | Q63HM9 | |
| EYIQDYVNIYGLKIW | 756 | Q12768 | |
| QYKKWYFELIIDQVD | 656 | Q15413 | |
| YTKVYNYVDWIKDTI | 286 | P35030 | |
| IYNLYSAKQIYAWEK | 126 | Q6P2C0 | |
| YKIWLKLALSTAYQY | 991 | Q5TAH2 | |
| RENYEKLWKLIAYYS | 371 | Q9NR99 |